Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Disopyramide

F Morady, M M Scheinman, J Desai

    Annals of Internal Medicine
    |March 1, 1982
    PubMed
    Summary
    This summary is machine-generated.

    Disopyramide effectively treats atrial and ventricular arrhythmias, similar to other type I antiarrhythmics. However, caution is advised in patients with sick sinus syndrome or congestive heart failure due to potential adverse effects.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    A randomised study of encorafenib, cetuximab, and FOLFIRI versus FOLFIRI with or without bevacizumab in BRAF V600E-mutant colorectal cancer: BREAKWATER Cohort 3.

    Annals of oncology : official journal of the European Society for Medical Oncology·2026
    Same author

    Quality of life with encorafenib plus cetuximab with or without binimetinib treatment in patients with BRAF V600E-mutant metastatic colorectal cancer: patient-reported outcomes from BEACON CRC.

    ESMO open·2022
    Same author

    Management of adverse events from the treatment of encorafenib plus cetuximab for patients with BRAF V600E-mutant metastatic colorectal cancer: insights from the BEACON CRC study.

    ESMO open·2021
    Same author

    Diagnosis and management of tropomyosin receptor kinase (TRK) fusion sarcomas: expert recommendations from the World Sarcoma Network.

    Annals of oncology : official journal of the European Society for Medical Oncology·2020
    Same author

    Do most premature babies get discharged by the expected date of delivery?

    Journal of perinatology : official journal of the California Perinatal Association·2020
    Same author

    Long-term efficacy of imatinib mesylate in patients with advanced Tenosynovial Giant Cell Tumor.

    Scientific reports·2019
    Same journal

    Correction to I.M. Matters News: Sleep medicine for seniors.

    Annals of internal medicine·2026
    Same journal

    Adverse Events After Same-Day COVID-19 and Influenza Vaccination Versus Influenza Vaccination Alone : A Target Trial Emulation.

    Annals of internal medicine·2026
    Same journal

    Leveraging Real-World Evidence to Inform Regulatory, Clinical, and Coverage Decisions Related to Glucagon-Like Peptide-1-Based Therapies: Synopsis of a National Institute of Diabetes and Digestive and Kidney Diseases Workshop.

    Annals of internal medicine·2026
    Same journal

    Methodological Approaches to Real-World Evidence Generation for Glucagon-like Peptide-1-Based Therapies: Synopsis of a National Institute of Diabetes and Digestive and Kidney Diseases Workshop.

    Annals of internal medicine·2026
    Same journal

    Weekly and Biweekly Treatment With Bofanglutide Versus Semaglutide in Chinese Patients With Type 2 Diabetes : A Phase 2b Randomized Clinical Trial.

    Annals of internal medicine·2026
    Same journal

    Grappling with GLP-1 prescribing.

    Annals of internal medicine·2026
    See all related articles

    Area of Science:

    • Cardiology
    • Pharmacology

    Background:

    • Disopyramide is a type I antiarrhythmic drug.
    • Its therapeutic applications and safety profile require detailed understanding.

    Purpose of the Study:

    • To review the therapeutic uses of disopyramide.
    • To highlight its safety considerations in specific patient populations.

    Main Methods:

    • Literature review of clinical data on disopyramide.
    • Analysis of efficacy and adverse event profiles.

    Main Results:

    • Disopyramide shows efficacy comparable to quinidine and procainamide for arrhythmias.
    • Potential for sinus node suppression necessitates caution in sick sinus syndrome.
    • Generally safe in bundle branch block and AV block.

    Related Experiment Videos

  • Risk of precipitating ventricular tachycardia/fibrillation exists.
  • Use with extreme caution in congestive heart failure patients.

    • Conclusions:

    • Disopyramide is a viable option for certain arrhythmias.
    • Careful patient selection and monitoring are crucial for safe and effective use.
    • Contraindicated or requires extreme caution in patients with specific cardiac conditions.